CLINICAL_TRIALS
research
· 2014-02-04
Clinical Trial Update: A Study to Evaluate the Baseline Follicle Stimulating Hormone, Ovarian Volume and Antral Follicle Count as Prognostic Factors of the Outcome of In-vitro Fertilisation/Intracytosolic Sperm Injection in Infertile Patients Receiving Gonal f for Controlled Ovarian Hyperstimulation
Summary
This ClinicalTrials.gov entry reports a completed study evaluating baseline FSH, ovarian volume and antral follicle count as prognostic factors for IVF/ICSI out…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility | Status: COMPLETED